Search

everythinglearnresearchcommunity

for

Search:↓

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Targeted cancer therapies often cause serious skin problems that need careful management.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Hair changes can indicate systemic diseases or medication effects.

Panitumumab can cause excessive ear hair growth.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

EGFR inhibitors can cause unusual localized hair growth.

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Cancer treatments often cause skin, nail, and hair problems.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.